Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials.
Wells JC, Sidhu A, Ding K, Smoragiewicz M, Heng DYC, Shepherd FA, Ellis PM, Bradbury PA, Jonker DJ, Siu LL, Gelmon KA, Karapetis C, Shapiro J, Nott L, O'Callaghan CJ, Parulekar WR, Seymour L, Monzon JG.
Wells JC, et al. Among authors: monzon jg.
Oncologist. 2022 Mar 11;27(3):e286-e293. doi: 10.1093/oncolo/oyac020.
Oncologist. 2022.
PMID: 35274718
Free PMC article.